prof quentin pankhurst

Profile Image
Contacts
  • Prof
  • Quentin
  • Andrew
  • Pankhurst
  • Prof Quentin Pankhurst
  • Ex: 51124
  • q.pankhurst@ucl.ac.uk
  • https://iris.ucl.ac.uk/iris/extResource/image/01/QAPAN40
  • 1994-01-24
Appointment
  • ACAPRO
  • 2011-10-01
  • 0.6
  • Professor of Physics Director Institute of Biomedical Engineering
  • Head of Department
  • EN
  • Institute of Biomedical Engineering
  • ENG
  • Faculty of Engineering Science
Joined UCL
  • 1994-01-24

Research Summary

As a research scientist, Pankhurst runs research programmes in bio- and nanomagnetism aimed at making practical advances in the use of magnetic nanoparticles in healthcare. These include a medical tool for breast cancer staging; a molecular imaging microscope for living cells; and the development of multi-functional nanoparticles for therapy and diagnostics.
Research Activities
  • 1638
  • DNA replication licensing and cell proliferation
  • 6202
  • Development of Rapid Prototypes for Muscle Augmentation Using Magnetic Augmentation
  • 1170
  • Effect of Tumour Biology on Therapeutic Response
  • 2418
  • Self propagating high temperature synthesis
  • 1604
  • Staphylococci
  • 857
  • Understanding the role of stem cells in cancer development

Academic Background

  • Award Year
    Qualification
     
    Institution
  • 1986
    PhD
    Doctor of Philosophy
    University of Liverpool
  • 1982
    BSc Hons
    Bachelor of Science (Honours)
    University of Canterbury

Biography

In May 2008, UCL and the Royal Institution of Great Britain entered into a five-year programme of Joint Research Activities in healthcare biomagnetics, led by Quentin Pankhurst, who was both appointed as Director of the Davy-Faraday Research Laboratory at the RI, and retained as a part-time Professor of Physics at UCL. At the RI, Pankhurst runs research programmes in bio- and nanomagnetism aimed at making practical advances in the use of magnetic nanoparticles in healthcare. These include medical imaging devices, targeted regenerative medicine, molecular imaging microscopy for living cells, and the development of multi-functional nanoparticles for therapy and diagnostics. Pankhurst is also a founder and the current CTO of Endomagnetics Ltd, a spin-out company which in 2010 gained a CE mark for, and started selling, the SentiMag - an intra-operative medical device for breast cancer surgery.

Additional Information
  • CMR
Collaborators
  • RBPED84
  • prof barbara pedley
  • DHOCH16
  • prof daniel hochhauser
  • HJSTA69
  • prof hans stauss
  • GBURR49
  • dr gaetano burriesci
  • RDAYX34
  • dr richard day
  • ITGOU27
  • prof ivan gout
  • LNIKI25
  • dr leonid nikitenko
  • DLSEL05
  • prof dave selwood
  • SNAIR26
  • dr sean nair
  • MSING16
  • prof mervyn singer
  • AVEMM74
  • dr anton emmanuel
  • IPPAR53
  • prof ivan parkin
  • MWIDS82
  • prof martin widschwendter
  • PCBEA63
  • prof paul beard
  • KSTOE64
  • dr kai stoeber
  • SMJAN15
  • dr samuel janes
  • JGODO41
  • prof jasminka godovac-zimmermann
  • MFLYT72
  • prof mark lythgoe
  • CHBOS19
  • prof chris boshoff
  • EARST22
  • dr erik arstad